Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-05-03
1998-12-01
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514172, 514173, 514176, 514182, 540 2, 540 28, 540 41, 540 44, 540 45, 540106, 540107, 540108, 540114, 540116, 552520, 552612, 552646, 552648, 552650, A61K 3156, A61K 3158, C07J 100, C07J 2100, C07J 1700, C07J 4100, C07J 4300
Patent
active
058439331
ABSTRACT:
Compounds of formula I ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings indicated in the description, are described, as well as processes for their production, pharmaceutical preparations containing these compounds as well as their use for treatment of diseases. The compounds have antigestagenic, antiglucocorticoid, antimineralocorticoid and antiandrogenic properties.
REFERENCES:
patent: 4386085 (1983-05-01), Teutsch et al.
patent: 4808710 (1989-02-01), de Jongh et al.
patent: 4861763 (1989-08-01), Cook et al.
patent: 4870069 (1989-09-01), Ottow et al.
patent: 4874754 (1989-10-01), Nique et al.
patent: 4900725 (1990-02-01), Nioie et al.
patent: 4921846 (1990-05-01), Nedelec et al.
patent: 4978657 (1990-12-01), Teutsch et al.
Neef, et al, Tetrahedron Letters, 24(47), pp. 5205-5208 (1983).
Bardon et al., Cancer Research 47, pp. 1441-1448 (Mar. 1, 1987).
Schneider et al., European Journal of Cancer and Clinical Oncology, vol. 25, No. 4, pp. 691-701 (1989).
P.J. Stang, M. Hanack and L.R. Subramanian, Synthesis, pp. 85, 106-107 115-117 (1982).
J.E. McMurry and S. Mohanraj, Tetrahedron Letters, 24, No. 27, pp. 2723-2726 (1983).
X. Lu and J. Zhu, Communications, pp. 726-727 (1987).
Yamamoto et al., Communications, pp. 564-565 (1986).
Q.-Y. Chen and Z.-Y. Yang, Tetrahedron Letters 27, No. 10, pp. 1171-1174 (1986).
Echavarren and J.K. Stille, J. Am. Chem. Soc. 1987, 109, pp. 5478-5486.
Bailey, T.J., Tetrahedron Letters, 27, No. 37, pp. 4407-4410 (1986).
Ishikura et al., Synthesis (1984), p. 936-938.
Volz, H., Kontakte (Darmstadt) 1986 (3), pp. 12-19.
Ishikura et al., Chem. Pharm. Bull. 33 (11), 4755-4763 (1984).
Hageman, Org. Reactions 7, 198 (1935).
Hoshino et al., Bull. Chem. Soc. Jpn. 61, 3008-3010 (1988).
Daniewski et al., J. Org. Chem. 1982, 47 2993-2995.
Stille, Van John K., Angew. Chem. 98 (1986), pp. 504-519.
Fried et al., "Organic Reactions in Steroid Chemistry", Van Nostrand Reinhold Co., 1972, vol. 1 and 2.
Neef et al., "Influence of Bulky 11.beta.-Substituents on Reactivity of Estrene Derivatives," Tetrahedron Letters, vol. 24, No. 47, pp. 5205-5208 (1983).
Kloosterboer et al., "Screening of Anti-Progestagens by Receptor Studies and Bioassays," J. Steroid Biochem., vol. 31, No. 48, pp. 567-571 (1988).
Grant & Hackh's Chemical Dictionary, pp. 39, 219, 554.
Neef et al., "Influence of Bulky 11.beta.-Substitiuents on Reactivity of Estrene Derivatives", Tetrahedron Ltrs., vol. 24, No. 47, pp. 5205-5208, 1983.
Teutsch et al., "11.beta.-Substituted Steroids, an Original Pathway to Anti-hormones", J. Steroid Biochem., vol. 31, No. 4B, pp. 549-565, 1988.
Philibert et al., "Properties of the Cytoplasmic Progestin-Binding Protein in the Rabbit Uterus", Endocrinology 101, 1850 (1977).
Beier Sybille
Cleve Arwed
Elger Walter
Neef Gunter
Ottow Eckhard
Badio Barbara
Robinson Allen J.
Schering Aktiengesellschaft
LandOfFree
11.beta.-aryl-4-estrenes, process for their production as well a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11.beta.-aryl-4-estrenes, process for their production as well a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11.beta.-aryl-4-estrenes, process for their production as well a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395767